NWPF

News ArchivesRead News

Reduced Diet May Offer Parkinson?s Help

Tuesday December 19, 2006

ISLAMABAD, December 15, 2006(Park Tribune) - A long-term low calorie diet, already reported to extend life span, may also offer protection from Parkinson’s disease- at least in monkeys.

Rhesus monkeys fed a diet that had 30 percent fewer calories than normal were less affected by a toxin that produces a Parkinson’s-like condition, researchers reported Monday.

Previous studies of similar reductions in food intake have shown that it extends the life span of mice.

The new study, by Mark P. Mattson of the National Institute on Aging, is reported in Proceedings of the National Academy of Science.

A team of researchers fed one group of monkeys the low calorie diet for six months, during which they lost about 12 percent of body weight compared to monkeys fed a normal diet.

Then both groups of primates were given a toxin which causes damage similar to Parkinson’s disease, causing the degeneration of dopamine neurons in the brain.

Movement was affected in all monkeys, but the ability to move and speed of movement were greater in the low-calorie monkeys than in those that had been fed normally.

The researchers found that the monkeys on a restricted diet had significantly higher concentrations than normal weight animals of two chemicals that protect nerve cells, BNDF and GNDF.

Intermittent fasting has been shown to increase levels of BNDF in rodents, the researchers noted. GNDF, they said, currently is being given to Parkinson’s patients in clinical trials.

"The present findings suggest the protective effect of reduced-calorie diets may result from the up-regulation of GNDF and BNDF expression," they wrote.

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement